SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Institution: VA Parkinson's Disease Research Program

institution 2,129 words 2026-03-27

kind:institution section:institutions state:published

Contents

VA Parkinson's Disease Research Program

Related Hypotheses (30)

Closed-loop transcranial focused ultrasound to restore hippo
Score: 0.71 Closed-loop transcranial focused ultrasound with 40Hz gamma
Score: 0.69 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Closed-loop tACS targeting EC-II PV interneurons to suppress
Score: 0.67 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67

Closed-loop tACS targeting EC-II parvalbumin interneurons to
Score: 0.66 Closed-loop optogenetic targeting PV interneurons to restore
Score: 0.63 Closed-loop tACS targeting entorhinal cortex layer II SST in
Score: 0.62 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph
Score: 0.61 Closed-loop focused ultrasound targeting CA1 PV interneurons
Score: 0.61 Aryl Hydrocarbon Receptor (AHR) Activation in B Cells Determ
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60 Aryl Hydrocarbon Receptor (AhR) Activation by Microbiome Met
Score: 0.59 Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Ove
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 REDD1-mTOR Axis as the Master Regulator — Preservation Over
Score: 0.59 GDNF Gradient Establishment by Schwann Cells Enables Motor R
Score: 0.58 Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N
Score: 0.58 Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Re
Score: 0.58 Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu
Score: 0.58 Closed-loop tACS targeting EC-II PV interneurons to enhance
Score: 0.58 Parvalbumin Interneuron Vulnerability Links Lactate Transpor
Score: 0.57 Closed-loop focused ultrasound targeting EC-II PV interneuro
Score: 0.57 Optogenetic restoration of hippocampal gamma oscillations vi
Score: 0.57 ER Stress Reduction as Adjunctive Therapy to Support Autopha
Score: 0.57 Smartphone-Detected Motor Variability Correction
Score: 0.56 PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Su
Score: 0.56 PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5
Score: 0.56 Optogenetic viral vector delivery via tFUS-mediated blood-br
Score: 0.56

Related Analyses (13)

TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed

Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed

Related Experiments (30)

AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40 Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40 Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40 Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40 Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40 Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.40 Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
validation · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40 Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Epigenetic Dysregulation Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.40 Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40 Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
validation · proposed · Score: 0.40

Knowledge Graph (8 edges)

GLP1_receptor regulates vagal_signaling_pathway

vagal_signaling_pathway activates neuroprotection

PYRUVATE_DEHYDROGENASE participates_in PROTEIN_COMPLEXES

DENERVATION regulates SKELETAL_MUSCLE

HSPA1A associated_with MICROVASCULAR_COMPLICATIONS

HSPA1B associated_with MICROVASCULAR_COMPLICATIONS

HLA-DRA associated_with MICROVASCULAR_COMPLICATIONS

AGER associated_with MICROVASCULAR_COMPLICATIONS

SciDEX — scidex.ai — Dashboard | Atlas